Fetal growth velocity and body proportion in the assessment of growth
L Hiersch, N Melamed - American journal of obstetrics and gynecology, 2018 - Elsevier
Fetal growth restriction implies failure of a fetus to meet its growth potential and is associated
with increased perinatal mortality and morbidity. Therefore, antenatal detection of fetal …
with increased perinatal mortality and morbidity. Therefore, antenatal detection of fetal …
International estimated fetal weight standards of the INTERGROWTH21st Project
J Stirnemann, J Villar, LJ Salomon… - … in Obstetrics & …, 2017 - Wiley Online Library
Objective Estimated fetal weight (EFW) and fetal biometry are complementary measures
used to screen for fetal growth disturbances. Our aim was to provide international EFW …
used to screen for fetal growth disturbances. Our aim was to provide international EFW …
Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction
J Hong, S Kumar - Clinical Science, 2023 - portlandpress.com
Fetal growth restriction (FGR) leading to low birth weight (LBW) is a major cause of neonatal
morbidity and mortality worldwide. Normal placental development involves a series of highly …
morbidity and mortality worldwide. Normal placental development involves a series of highly …
Prediction and prevention of smallforgestationalage neonates: evidence from SPREE and ASPRE
Objectives To examine the effect of firsttrimester screening for preeclampsia (PE) on the
prediction of delivering a smallforgestationalage (SGA) neonate and the effect of …
prediction of delivering a smallforgestationalage (SGA) neonate and the effect of …
Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35–37 weeks' gestation
A Ciobanu, A Rouvali, A Syngelaki, R Akolekar… - American Journal of …, 2019 - Elsevier
Background Small for gestational age (SGA) neonates are at increased risk for perinatal
mortality and morbidity; however, the risks can be substantially reduced if the condition is …
mortality and morbidity; however, the risks can be substantially reduced if the condition is …
Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy
C Birdir, L Droste, L Fox, M Frank, J Fryze… - Pregnancy …, 2018 - Elsevier
Objectives The aim of this study was to investigate, whether maternal serum levels of sFlt-1,
PlGF and PAPP-A at third trimester of pregnancy are associated with late-onset PE and …
PlGF and PAPP-A at third trimester of pregnancy are associated with late-onset PE and …
Biophysical and biochemical markers at 35–37 weeks' gestation in the prediction of adverse perinatal outcome
N Valiño, G Giunta, DM Gallo… - … in Obstetrics & …, 2016 - Wiley Online Library
Objective To investigate the potential value of biophysical and biochemical markers at 35–
37 weeks' gestation in the prediction of adverse perinatal outcome. Methods This was a …
37 weeks' gestation in the prediction of adverse perinatal outcome. Methods This was a …
Biophysical and biochemical markers at 30–34 weeks' gestation in the prediction of adverse perinatal outcome
N Valiño, G Giunta, DM Gallo… - … in Obstetrics & …, 2016 - Wiley Online Library
Objective To investigate the potential value of biophysical and biochemical markers at 30–
34 weeks' gestation in the prediction of adverse perinatal outcome. Methods This was a …
34 weeks' gestation in the prediction of adverse perinatal outcome. Methods This was a …
Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester
J Miranda, M RodriguezLopez… - … in obstetrics & …, 2017 - Wiley Online Library
Objectives To compare the performance of thirdtrimester screening, based on estimated
fetal weight centile (EFWc) vs a combined model including maternal baseline …
fetal weight centile (EFWc) vs a combined model including maternal baseline …
Systematic review of maternal Placental Growth Factor levels in late pregnancy as a predictor of adverse intrapartum and perinatal outcomes
Aim This systematic review evaluates the utility of maternal Placental Growth Factor (PlGF)
when measured in late pregnancy (> 20 weeks) as a predictor of adverse obstetric and …
when measured in late pregnancy (> 20 weeks) as a predictor of adverse obstetric and …